ANDA 91514, held by Sciegen Pharms. Fluocinolone Acetonide.
As of Nov 15, 2026, ANDA 91514 (Fluocinolone Acetonide), held by Sciegen Pharms, was first approved by FDA on Jun 25, 2015, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 25, 2015 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fluocinolone Acetonide0.01% ยท oil;topical | Fluocinolone Acetonide | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
